Since osteosarcomas of osteoblastic and chondroblastic origin retain the expression of Fra-2 and its molecular targets, their application has been proposed for the differential diagnosis of bone-derived tumors [47]. The gene discussed is FOSL2; the disease is osteosarcoma.